Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | +1.56% | +6.56% | -18.75% |
16/04 | Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing | MT |
27/03 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
Sales 2022 | 1.98M 1.3M 108M | Sales 2023 | 1.19M 777K 64.79M | Capitalization | 16.49M 10.77M 898M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.96M -163M | Net income 2023 | -6M -3.92M -327M | EV / Sales 2022 | 7.87 x |
Net cash position 2022 | 12.51M 8.17M 681M | Net cash position 2023 | 6.98M 4.56M 380M | EV / Sales 2023 | 7.99 x |
P/E ratio 2022 |
-5.79
x | P/E ratio 2023 |
-2.64
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.95% |
1 day | +1.56% | ||
1 week | +6.56% | ||
Current month | -15.58% | ||
1 month | -15.58% | ||
3 months | -18.75% | ||
6 months | -21.69% | ||
Current year | -18.75% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 31/00/31 | |
Tim Luscombe
DFI | Director of Finance/CFO | - | 25/23/25 |
Rhiannon Jones
COO | Chief Operating Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Cooke
SEC | Corporate Secretary | 62 | 11/13/11 |
Robert Peach
BRD | Director/Board Member | 68 | 02/15/02 |
Warwick Tong
CHM | Chairman | - | 04/18/04 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.065 | +1.56% | 9,230 |
24/24/24 | 0.064 | +6.67% | 342,635 |
23/24/23 | 0.06 | -7.69% | 191,395 |
22/24/22 | 0.065 | +6.56% | 649 |
Delayed Quote Australian S.E., April 26, 2024 at 06:05 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-18.75% | 8.22M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ATX Stock